CN Stock MarketDetailed Quotes

002393 Tianjin Lisheng Pharmaceutical

Watchlist

17.45
-0.50-2.79%

Market Closed Dec 13 15:00 CST

4.50BMarket Cap23.90P/E (TTM)

Tianjin Lisheng Pharmaceutical Stock Forum

Moomoo AI

Feb 3 18:18

Tianjin Lisheng Pharmaceutical's low P/E ratio is justified by its below-market growth. Investors see limited potential for earnings improvement, keeping the share price at current levels unless medium-term conditions improve.

Investors Don't See Light At End Of Tianjin Lisheng Pharmaceutical Co.,Ltd.'s (SZSE:002393) Tunnel And Push Stock Down 25%

No comment yet

Heat List

Overall

No Data

Investment Theme

State-owned Enterprise Reform

Intraday-1.75%

Specialized, Special and New

Intraday-1.91%